AU4220493A
(en)
*
|
1992-05-07 |
1993-11-29 |
Merck & Co., Inc. |
New quinazolines as inhibitors of hiv reverse transcriptase
|
DE4214829A1
(de)
*
|
1992-05-10 |
1993-11-11 |
Boehringer Mannheim Gmbh |
Verwendung von tricyclischen Pyrimidin-Derivaten als antivirale Arzneimittel
|
DE4214830A1
(de)
*
|
1992-05-10 |
1993-11-11 |
Boehringer Mannheim Gmbh |
Neue Tricyclische Thiazolo- und Thiazino-Derivate und diese enthaltende Arzneimittel
|
US6177435B1
(en)
|
1992-05-13 |
2001-01-23 |
Glaxo Wellcome Inc. |
Therapeutic combinations
|
ES2138624T3
(es)
*
|
1992-05-13 |
2000-01-16 |
Wellcome Found |
Combinaciones terapeuticas.
|
US5646154A
(en)
*
|
1992-10-07 |
1997-07-08 |
Sumitomo Pharmaceuticals Co., Ltd. |
Pharmaceutical compositions for inhibiting the formation of tumor necrosis factor
|
WO1995012583A1
(fr)
*
|
1993-11-05 |
1995-05-11 |
Merck & Co., Inc. |
Nouvelles quinazolines utilisees comme inhibtiteurs de la transcriptase inverse du vih
|
US5434152A
(en)
*
|
1993-11-08 |
1995-07-18 |
Merck & Co., Inc. |
Asymmetric synthesis of (S)-(-)-6-chloro-4- cyclopropyl-3,4-dihydro-4-[(2-pyridyl)ethynyl]-2(1H)-quinazolinone
|
DE4414476A1
(de)
*
|
1994-04-26 |
1995-11-02 |
Bayer Ag |
Substituierte Cyclopropylcarbonyl-phenylaminosulfonyl-harnstoffe
|
US6124302A
(en)
*
|
1997-04-09 |
2000-09-26 |
Dupont Pharmaceuticals |
4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors
|
HRP980143A2
(en)
*
|
1997-04-09 |
1999-02-28 |
Soo Sung Ko |
4,4-disubstituted-3,4-dihydro-2 (1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
|
CA2322203A1
(fr)
*
|
1998-03-27 |
1999-10-07 |
Jeffrey W. Corbett |
3,4-dihydro-2(1h)-quinazolinthiones substitues en 4,4, leur preparation et leur utilisation en tant qu'inhibiteurs de la transcriptase inverse du vih
|
US6391005B1
(en)
|
1998-03-30 |
2002-05-21 |
Agilent Technologies, Inc. |
Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
|
WO2000000479A1
(fr)
*
|
1998-06-30 |
2000-01-06 |
Du Pont Pharmaceuticals Company |
1,3-benzodiazepin-2-ones et 1,3-benzoxazepin-2-ones utilisees comme inhibiteurs de la reverse-transcriptase du vih
|
WO2000029391A1
(fr)
*
|
1998-11-19 |
2000-05-25 |
Du Pont Pharmaceuticals Company |
Processus visant la preparation de quinazolinones
|
CA2370141A1
(fr)
*
|
1999-05-26 |
2000-12-07 |
James D. Rodgers |
Inhibiteurs de transcriptase inverse du vih a base de 1,4-benzodiazepin-2-ones
|
US6593337B1
(en)
|
1999-10-19 |
2003-07-15 |
Bristol-Myers Squibb Pharma Company |
Tricyclic compounds useful as HIV reverse transcriptase inhibitors
|
DE19951702A1
(de)
*
|
1999-10-27 |
2001-05-03 |
Aventis Pharma Gmbh |
Verwendung von 2-Amino-3,4-dihydro-chinazolinen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
|
US6175009B1
(en)
|
1999-11-18 |
2001-01-16 |
Dupont Pharmaceuticals Company |
Process for the preparation of quinazolinones
|
JP2003514900A
(ja)
|
1999-11-23 |
2003-04-22 |
スミスクライン・ビーチャム・コーポレイション |
CSBP/p38キナーゼ阻害剤としての3,4−ジヒドロ−(1H)−キナゾリン−2−オン化合物
|
US7235551B2
(en)
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
US6596729B2
(en)
*
|
2000-07-20 |
2003-07-22 |
Bristol-Myers Squibb Company |
Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
|
ZA200300255B
(en)
|
2000-07-20 |
2004-09-28 |
Bristol Myers Squibb Pharma Co |
Tricyclic 2-pyridone compounds useful as HIV reverse transcriptase inhibitors.
|
NZ524806A
(en)
|
2000-10-23 |
2006-03-31 |
Smithkline Beecham Corp |
Tri-substituted 8H-pyrido[2,3-d]pyrimidin-7-one compounds
|
US6435468B1
(en)
|
2000-10-26 |
2002-08-20 |
Dror Simchoni |
Rolling weighted base
|
US8641644B2
(en)
|
2000-11-21 |
2014-02-04 |
Sanofi-Aventis Deutschland Gmbh |
Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
|
US6946469B2
(en)
|
2001-03-28 |
2005-09-20 |
Bristol-Myers Squibb Pharma Company |
Cyanamide, alkoxyamino, and urea derivatives of 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones as HIV reverse transcriptase inhibitors
|
US7015214B2
(en)
|
2001-03-28 |
2006-03-21 |
Bristol-Myers Squibb Pharma Company |
Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazepine as HIV reverse transcriptase inhibitors
|
CN1649591A
(zh)
|
2001-04-19 |
2005-08-03 |
布里斯托尔-迈尔斯斯奎布公司 |
可用作hiv逆转录酶抑制剂的三环化合物
|
US7981056B2
(en)
|
2002-04-19 |
2011-07-19 |
Pelikan Technologies, Inc. |
Methods and apparatus for lancet actuation
|
US7025774B2
(en)
|
2001-06-12 |
2006-04-11 |
Pelikan Technologies, Inc. |
Tissue penetration device
|
AU2002315177A1
(en)
|
2001-06-12 |
2002-12-23 |
Pelikan Technologies, Inc. |
Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
|
US8337419B2
(en)
|
2002-04-19 |
2012-12-25 |
Sanofi-Aventis Deutschland Gmbh |
Tissue penetration device
|
US7344507B2
(en)
|
2002-04-19 |
2008-03-18 |
Pelikan Technologies, Inc. |
Method and apparatus for lancet actuation
|
US9795747B2
(en)
|
2010-06-02 |
2017-10-24 |
Sanofi-Aventis Deutschland Gmbh |
Methods and apparatus for lancet actuation
|
US9226699B2
(en)
|
2002-04-19 |
2016-01-05 |
Sanofi-Aventis Deutschland Gmbh |
Body fluid sampling module with a continuous compression tissue interface surface
|
EP1404235A4
(fr)
|
2001-06-12 |
2008-08-20 |
Pelikan Technologies Inc |
Procede et appareil pour un dispositif de lancement de lancette integre sur une cartouche de prelevement de sang
|
DE60238119D1
(de)
|
2001-06-12 |
2010-12-09 |
Pelikan Technologies Inc |
Elektrisches betätigungselement für eine lanzette
|
US9427532B2
(en)
|
2001-06-12 |
2016-08-30 |
Sanofi-Aventis Deutschland Gmbh |
Tissue penetration device
|
DE10161767A1
(de)
*
|
2001-12-15 |
2003-06-26 |
Merck Patent Gmbh |
2-Guanidino-4-heterocyclyl-chinazoline
|
US7901362B2
(en)
|
2002-04-19 |
2011-03-08 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US8784335B2
(en)
|
2002-04-19 |
2014-07-22 |
Sanofi-Aventis Deutschland Gmbh |
Body fluid sampling device with a capacitive sensor
|
US7491178B2
(en)
|
2002-04-19 |
2009-02-17 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US7229458B2
(en)
|
2002-04-19 |
2007-06-12 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US7909778B2
(en)
|
2002-04-19 |
2011-03-22 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US7297122B2
(en)
|
2002-04-19 |
2007-11-20 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US7547287B2
(en)
|
2002-04-19 |
2009-06-16 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US9248267B2
(en)
|
2002-04-19 |
2016-02-02 |
Sanofi-Aventis Deustchland Gmbh |
Tissue penetration device
|
US7892185B2
(en)
|
2002-04-19 |
2011-02-22 |
Pelikan Technologies, Inc. |
Method and apparatus for body fluid sampling and analyte sensing
|
US7674232B2
(en)
|
2002-04-19 |
2010-03-09 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US8579831B2
(en)
|
2002-04-19 |
2013-11-12 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for penetrating tissue
|
US9314194B2
(en)
|
2002-04-19 |
2016-04-19 |
Sanofi-Aventis Deutschland Gmbh |
Tissue penetration device
|
US9795334B2
(en)
|
2002-04-19 |
2017-10-24 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for penetrating tissue
|
US8702624B2
(en)
|
2006-09-29 |
2014-04-22 |
Sanofi-Aventis Deutschland Gmbh |
Analyte measurement device with a single shot actuator
|
US7232451B2
(en)
|
2002-04-19 |
2007-06-19 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
RU2004133811A
(ru)
|
2002-04-19 |
2005-04-20 |
Смитклайн Бичам Корпорейшн (US) |
Новые соединения
|
US8221334B2
(en)
|
2002-04-19 |
2012-07-17 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for penetrating tissue
|
US7976476B2
(en)
|
2002-04-19 |
2011-07-12 |
Pelikan Technologies, Inc. |
Device and method for variable speed lancet
|
US8360992B2
(en)
|
2002-04-19 |
2013-01-29 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for penetrating tissue
|
US7892183B2
(en)
|
2002-04-19 |
2011-02-22 |
Pelikan Technologies, Inc. |
Method and apparatus for body fluid sampling and analyte sensing
|
US7226461B2
(en)
|
2002-04-19 |
2007-06-05 |
Pelikan Technologies, Inc. |
Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
|
US8267870B2
(en)
|
2002-04-19 |
2012-09-18 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for body fluid sampling with hybrid actuation
|
US7331931B2
(en)
|
2002-04-19 |
2008-02-19 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
TW200409629A
(en)
|
2002-06-27 |
2004-06-16 |
Bristol Myers Squibb Co |
2,4-disubstituted-pyridine N-oxides useful as HIV reverse transcriptase inhibitors
|
EP1400244A1
(fr)
*
|
2002-09-17 |
2004-03-24 |
Warner-Lambert Company LLC |
Nouveaux quinazolinones spirocondensés et leur utilisation comme inhibiteurs de la phosphodiesterase
|
US8574895B2
(en)
|
2002-12-30 |
2013-11-05 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus using optical techniques to measure analyte levels
|
ATE476137T1
(de)
|
2003-05-30 |
2010-08-15 |
Pelikan Technologies Inc |
Verfahren und vorrichtung zur injektion von flüssigkeit
|
US7850621B2
(en)
|
2003-06-06 |
2010-12-14 |
Pelikan Technologies, Inc. |
Method and apparatus for body fluid sampling and analyte sensing
|
WO2006001797A1
(fr)
|
2004-06-14 |
2006-01-05 |
Pelikan Technologies, Inc. |
Element penetrant peu douloureux
|
EP1671096A4
(fr)
|
2003-09-29 |
2009-09-16 |
Pelikan Technologies Inc |
Procede et appareil permettant d'obtenir un dispositif de capture d'echantillons ameliore
|
EP1680014A4
(fr)
|
2003-10-14 |
2009-01-21 |
Pelikan Technologies Inc |
Procede et appareil fournissant une interface-utilisateur variable
|
US7822454B1
(en)
|
2005-01-03 |
2010-10-26 |
Pelikan Technologies, Inc. |
Fluid sampling device with improved analyte detecting member configuration
|
EP1706026B1
(fr)
|
2003-12-31 |
2017-03-01 |
Sanofi-Aventis Deutschland GmbH |
Procédé et appareil permettant d'améliorer le flux fluidique et le prélèvement d'échantillons
|
EP1751546A2
(fr)
|
2004-05-20 |
2007-02-14 |
Albatros Technologies GmbH & Co. KG |
Hydrogel imprimable pour biocapteurs
|
WO2005120365A1
(fr)
|
2004-06-03 |
2005-12-22 |
Pelikan Technologies, Inc. |
Procede et appareil pour la fabrication d'un dispositif d'echantillonnage de liquides
|
US9775553B2
(en)
|
2004-06-03 |
2017-10-03 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for a fluid sampling device
|
KR20070110081A
(ko)
*
|
2005-03-09 |
2007-11-15 |
머크 앤드 캄파니 인코포레이티드 |
퀴나졸린온 t-형 칼슘 채널 길항제
|
PE20061193A1
(es)
|
2005-03-25 |
2006-12-02 |
Glaxo Group Ltd |
DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
|
JP2008535822A
(ja)
|
2005-03-25 |
2008-09-04 |
グラクソ グループ リミテッド |
新規化合物
|
WO2006104917A2
(fr)
|
2005-03-25 |
2006-10-05 |
Glaxo Group Limited |
Procede de preparation de derives pyrido[2,3-d]pyrimidin-7-one et 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one
|
UY29440A1
(es)
|
2005-03-25 |
2006-10-02 |
Glaxo Group Ltd |
Nuevos compuestos
|
CA2610812A1
(fr)
*
|
2005-06-14 |
2006-12-28 |
Schering Corporation |
Inhibiteurs de l'aspartyl protease
|
US8686002B2
(en)
|
2005-08-21 |
2014-04-01 |
AbbVie Deutschland GmbH & Co. KG |
Heterocyclic compounds and their use as binding partners for 5-HT5 receptors
|
CN101225083A
(zh)
*
|
2007-01-16 |
2008-07-23 |
北京摩力克科技有限公司 |
四氢喹唑啉酮类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
US7928111B2
(en)
*
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
AU2013202912B2
(en)
*
|
2007-06-08 |
2016-10-27 |
Firmenich Incorporated |
Modulation of chemosensory receptors and ligands associated therewith
|
AU2008308092B2
(en)
*
|
2007-10-05 |
2013-07-11 |
Msd K.K. |
Benzoxazinone derivative
|
WO2009126900A1
(fr)
|
2008-04-11 |
2009-10-15 |
Pelikan Technologies, Inc. |
Procédé et appareil pour dispositif de détection d’analyte
|
US8586733B2
(en)
|
2008-07-31 |
2013-11-19 |
Senomyx, Inc. |
Processes and intermediates for making sweet taste enhancers
|
RU2511315C2
(ru)
|
2008-07-31 |
2014-04-10 |
Синомикс, Инк. |
Композиции, содержащие усилители сладкого вкуса, и способы их получения
|
US9375169B2
(en)
|
2009-01-30 |
2016-06-28 |
Sanofi-Aventis Deutschland Gmbh |
Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
|
US8965476B2
(en)
|
2010-04-16 |
2015-02-24 |
Sanofi-Aventis Deutschland Gmbh |
Tissue penetration device
|
US9000054B2
(en)
|
2010-08-12 |
2015-04-07 |
Senomyx, Inc. |
Method of improving stability of sweet enhancer and composition containing stabilized sweet enhancer
|
CN102775371B
(zh)
*
|
2012-07-26 |
2015-01-21 |
山东大学 |
一种取代噻二嗪类衍生物及其制备方法与应用
|
KR20150041040A
(ko)
|
2012-08-06 |
2015-04-15 |
세노믹스, 인코포레이티드 |
단맛 향미 개질제
|
US8722886B1
(en)
*
|
2012-11-13 |
2014-05-13 |
Bionumerik Pharmaceuticals, Inc. |
Methods for the total chemical synthesis of enantiomerically-pure 7-(2′-trimethylsilyl)ethyl camptothecin
|
JO3155B1
(ar)
|
2013-02-19 |
2017-09-20 |
Senomyx Inc |
معدِّل نكهة حلوة
|
CN103360398B
(zh)
*
|
2013-07-22 |
2015-03-25 |
山东大学 |
一种三唑并嘧啶类hiv-1逆转录酶抑制剂及其制备方法与应用
|
WO2017003724A1
(fr)
|
2015-07-01 |
2017-01-05 |
Crinetics Pharmaceuticals, Inc. |
Modulateurs de somatostatine et leurs utilisations
|
US11028068B2
(en)
|
2017-07-25 |
2021-06-08 |
Crinetics Pharmaceuticals, Inc. |
Somatostatin modulators and uses thereof
|
US11945813B2
(en)
|
2018-08-07 |
2024-04-02 |
Firmenich Incorporated |
5-substituted 4-amino-1H-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof
|
CN112480124A
(zh)
*
|
2020-12-16 |
2021-03-12 |
成都大学 |
三氟甲基取代的手性四氢吡咯[1,2-c]喹唑啉-3,5-二酮及其制备方法
|